76 – 90 of 103
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO--Part I
(
- Contribution to journal › Article
-
Mark
Contribution to case law summaries and comments: Tri-lingual
2011)(
- Book/Report › Book
-
Mark
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO – Part I
(
- Contribution to journal › Article
- 2010
-
Mark
Refusal to supply in the EU pharmaceutical sector under the rule of reason
(
- Contribution to journal › Article
-
Mark
Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were'Obvious to Try'Still Might Be Non-Obvious--Part I
(
- Contribution to journal › Article
- 2009
-
Mark
Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were “Obvious to Try” Still Might Be Non-Obvious – Part I
2009) In Chicago-Kent Journal of Intellectual Property (forthcoming)(
- Contribution to journal › Article
-
Mark
The rule of reason under Article 82 EC After Sot Lelos kai Sia
2009)(
- Working paper/Preprint › Working paper
-
Mark
“Restoring the balance: The patentability of DNA-related technology in the US and Europe”
2009) Scholarship speech prepared for the AWAPATENT Foundation for the Promotion of Scientific Research in the Area of Intellectual Property Rights. p.1-10(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2008
-
Mark
The US Examination of Nonobviousness After KSR v. Teleflex with Special Emphasis on DNA-Related Inventions
(
- Contribution to journal › Article
-
Mark
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar?- Del I (When does US patent law regard a biotechnological invention as complete and useful?)
(
- Contribution to journal › Article
-
Mark
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? - Del II (When does European patent law regard a biotechnological invention as complete and having an industrial application?)
(
- Contribution to journal › Article
-
Mark
Es bleibet dabei: Eine schwedische Stellungnahme zur europäischen Debatte über den absoluten Erzeugnisschutz bei der DNA Patentierung
(
- Contribution to journal › Article
-
Mark
Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk
2008) In GRUR International (Gewerblicher Rechtsschutz und Urheberrecht)(
- Contribution to journal › Article
-
Mark
Standing in the shadows of Brüstle: ordre public & the patentability of human embryonic stem cell technology in Germany and at the EPO
2008) In Historielärarnas Förenings Årsskrift(
- Contribution to journal › Article
-
Mark
Is In re Deuel still the law of the land? The US examination of nonobviousness after KSR v. Teleflex with special emphasis on DNA related inventions
2008) In Historielärarnas Förenings Årsskrift(
- Contribution to journal › Article